Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 22 2 2022
medline: 21 4 2022
entrez: 21 2 2022
Statut: ppublish

Résumé

Serum ferritin (SF) is frequently elevated in classical Hodgkin lymphoma (cHL). We report on its prognostic significance in an unselected series of 529 cHL patients treated with state-of-the-art therapy. Higher baseline levels correlated with markers of advanced/aggressive disease. SF levels were significantly higher in male and older patients, those with high body mass index and mixed cellularity histology. The strongest correlation was recorded between SF and complement reactive protein (CRP) levels. Gender-specific SF cutoffs which provided the best discrimination in terms of freedom from progression (FFP) were identified. In multivariate analysis elevated SF levels, advanced stage and high lactate dehydrogenase (LDH) were independent prognostic factors of inferior FFP. SF also appears to retain independent prognostic significance for progression-free survival (PFS) but not for overall survival (OS). In conclusion, SF levels in cHL reflect disease activity and are associated with adverse patient outcomes.

Identifiants

pubmed: 35188040
doi: 10.1080/10428194.2021.2010054
doi:

Substances chimiques

Biomarkers 0
Ferritins 9007-73-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-812

Commentaires et corrections

Type : CommentIn

Auteurs

Stamatios Karakatsanis (S)

Third Department of Internal Medicine and Laboratory, National and Kapoditrian University of Athens, School of Medicine, "Sotiria" General Hospital, Athens, Greece.

Fotios Panitsas (F)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Maria Arapaki (M)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Dimitrios Galopoulos (D)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

John V Asimakopoulos (JV)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Athanassios Liaskas (A)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Chrysovalantou Chatzidimitriou (C)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Marina Belia (M)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Elianna Konstantinou (E)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Ioannis Vassilopoulos (I)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Stamatis S Papadatos (SS)

Third Department of Internal Medicine and Laboratory, National and Kapoditrian University of Athens, School of Medicine, "Sotiria" General Hospital, Athens, Greece.

Sotirios Sachanas (S)

Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece.

Maria Efstathopoulou (M)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece.

Xanthoula Yiakoumis (X)

Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece.

Vassilios Pardalis (V)

First Department of Internal Medicine, Propaedeutic, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.

Theodoros Iliakis (T)

First Department of Internal Medicine, Propaedeutic, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.

Nefeli Giannakopoulou (N)

First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Maria Dimou (M)

First Department of Internal Medicine, Propaedeutic, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.

Sevastianos Chatzidavid (S)

First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

George Boutsikas (G)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Kyriaki Petevi (K)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Alexandros Kanellopoulos (A)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Gabriella Gainaru (G)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Eleni Variamis (E)

First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Marina P Siakantaris (MP)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Marie-Christine Kyrtsonis (MC)

First Department of Internal Medicine, Propaedeutic, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.

Eleni Plata (E)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Panayiotis Tsaftaridis (P)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Maria N Dimopoulou (MN)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Nora-Athina Viniou (NA)

First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Konstantinos N Syrigos (KN)

Third Department of Internal Medicine and Laboratory, National and Kapoditrian University of Athens, School of Medicine, "Sotiria" General Hospital, Athens, Greece.

Gerassimos A Pangalis (GA)

Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece.

Panayiotis Panayiotidis (P)

First Department of Internal Medicine, Propaedeutic, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.

Kostas Konstantopoulos (K)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Maria K Angelopoulou (MK)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Theodoros P Vassilakopoulos (TP)

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH